This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Aug;13(3):90.

doi: 10.1136/ebmh.13.3.90.

Antipsychotic polypharmacy is not associated with increased mortality from natural causes in patients with schizophrenia compared to monotherapy

Arif Khan¹

Affiliations

PMID: 20682830
DOI: 10.1136/ebmh.13.3.90

Comment

Antipsychotic polypharmacy is not associated with increased mortality from natural causes in patients with schizophrenia compared to monotherapy

Arif Khan. Evid Based Ment Health. 2010 Aug.

. 2010 Aug;13(3):90.

doi: 10.1136/ebmh.13.3.90.

Author

Arif Khan¹

Affiliation

¹ Duke University Medical Centre, Durham, North Carolina, USA.

PMID: 20682830
DOI: 10.1136/ebmh.13.3.90

No abstract available

PubMed Disclaimer

Comment on

Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study.
Baandrup L, Gasse C, Jensen VD, Glenthoj BY, Nordentoft M, Lublin H, Fink-Jensen A, Lindhardt A, Mortensen PB. Baandrup L, et al. J Clin Psychiatry. 2010 Feb;71(2):103-8. doi: 10.4088/JCP.08m04818yel. Epub 2009 Nov 3. J Clin Psychiatry. 2010. PMID: 19895781

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.